Your browser doesn't support javascript.
loading
Crystal structure of an anti-idiotype variable lymphocyte receptor.
Collins, Bernard C; Nakahara, Hiro; Acharya, Sharmistha; Cooper, Max D; Herrin, Brantley R; Wilson, Ian A.
Affiliation
  • Collins BC; Department of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
  • Nakahara H; Emory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
  • Acharya S; Department of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
  • Cooper MD; Emory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
  • Herrin BR; Emory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
  • Wilson IA; Department of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Acta Crystallogr F Struct Biol Commun ; 73(Pt 12): 682-687, 2017 Dec 01.
Article in En | MEDLINE | ID: mdl-29199989
ABSTRACT
Variable lymphocyte receptors (VLRs), the leucine-rich repeat (LRR)-based antigen receptors of jawless fish, have great utility in a wide variety of biochemical and biological applications, similar to classical Ig-based antibodies. VLR-based reagents may be particularly useful when traditional antibodies are not available. An anti-idiotype lamprey VLR, VLR39, has previously been identified that recognizes the heavy-chain CDR3 of the B-cell receptor (BCR) of a leukemic clone from a patient with chronic lymphocytic leukemia (CLL). VLR39 was used successfully to track the re-emergence of this clone in the patient following chemotherapy. Here, the crystal structure of VLR39 is presented at 1.5 Šresolution and compared with those of other protein-specific VLRs. VLR39 adopts a curved solenoid fold and exhibits substantial structural similarity to other protein-binding VLRs. VLR39 has a short LRRCT loop that protrudes outwards away from the concave face and is similar to those of its protein-specific VLR counterparts. Analysis of the VLR39-BCR interaction by size-exclusion chromatography and biolayer interferometry using the scFv version of the BCR confirms that VLR39 recognizes the BCR Fv region. Such VLR-based reagents may be useful for identifying and monitoring leukemia in CLL patients and in other clinical diagnostic assays.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen Type of study: Prognostic_studies Limits: Humans Language: En Journal: Acta Crystallogr F Struct Biol Commun Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen Type of study: Prognostic_studies Limits: Humans Language: En Journal: Acta Crystallogr F Struct Biol Commun Year: 2017 Type: Article Affiliation country: United States